About: Is efficacy of repeated intradetrusor botulinum toxin type A (Dysport) injections dose dependent? Clinical and urodynamic results after four injections in patients with drug-resistant neurogenic detrusor overactivity

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Is efficacy of repeated intradetrusor botulinum toxin type A (Dysport) injections dose dependent? Clinical and urodynamic results after four injections in patients with drug-resistant neurogenic detrusor overactivity Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 31 January 2009

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 2009 (uk) im Januar 2009 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 31 January 2009 (en) artículu científicu espublizáu en xineru de 2009 (ast)
publication date	wds:Q83275316-73D60262-0342-4A95-800B-E696F74104E2
publication date	2009-01-31 00:00:00Z (xsd:dateTime)
cites work	wds:Q83275316-04D7E15A-A293-44BC-9E39-73DE713D0497 wds:Q83275316-0B7D723C-4BFF-4CF2-A8A1-AD453EFFD143 wds:Q83275316-0DF638F8-8FC8-4622-A0B7-3AD45A7F4788 wds:Q83275316-1290A8B8-455F-464B-BC48-E4316D917201 wds:Q83275316-2831B2FB-009F-4266-91C1-C9665B2492FA wds:Q83275316-2B2A4DB2-94B6-4BC9-87C3-A979B1618F50 wds:Q83275316-2BA01797-5BB5-405C-B8C4-FA9863E845A0 wds:Q83275316-39FE8C2D-B2FF-4711-8A1A-0B33803812E8 wds:Q83275316-3D7B8261-6F38-44BB-9535-17584C516BA5 wds:Q83275316-4A3BDCC7-5BE5-4738-B1FD-45C06C627F2C wds:Q83275316-4BABF2EE-BCAE-4D35-BB8B-7AFD178871AB wds:Q83275316-4C6B717F-DB48-4EF8-96DC-3965E4853469 wds:Q83275316-524CEE29-A675-40B5-910D-69D5CF41E422 wds:Q83275316-567011C2-5143-457E-98C9-9AE392EDE96B wds:Q83275316-663A1D50-1AC4-494D-AE14-66C72F836828 wds:Q83275316-6DB32E6A-C9F0-48F7-998D-0EF2731B1F49 wds:Q83275316-8062CBD9-B61A-4E82-BCCF-CCEF51D7CF53 wds:Q83275316-97EAA192-F94B-4C9E-A4CC-637624C8F35C wds:Q83275316-A90B63E2-CB00-4D90-87C3-FC6B06891692 wds:Q83275316-AD951F38-91CF-4758-8F1C-87913F8C91AA wds:Q83275316-BE43CBDF-E08B-4D01-9D23-353700669456 wds:Q83275316-CC210BC2-32E3-4060-BFD8-F163AFFF1877 wds:Q83275316-CD6C3C76-FB22-4985-9DAC-E37E828149CF wds:Q83275316-D8D354FE-244C-4EF8-8BAC-BC62BB15C487 wds:Q83275316-DFBF7F02-E837-4A48-BDB6-ECBBCFB458EF wds:Q83275316-F59CBD62-D8D7-4557-8425-D5D2B792CAF9 wds:Q83275316-F6037B53-995E-46BA-9B59-805C9C59B8C4
cites work	New therapeutic options for refractory neurogenic detrusor overactivity Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results Botulinum toxin as a new therapy option for voiding disorders: current state of the art. Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder Botulinum-a toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity Neurogenic detrusor overactivity treated with english botulinum toxin a: 8-year experience of one single centre Motor nerve sprouting in human orbicularis muscle after botulinum A injection. A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin. Botulinum toxin-type A in the treatment of drug-resistant neurogenic detrusor overactivity secondary to traumatic spinal cord injury. Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type A and correlations with lower urinary tract symptoms and urodynamic changes. Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity Histologic features in the urinary bladder wall affected from neurogenic overactivity--a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A What is the optimum dose of type A botulinum toxin for treating neurogenic bladder overactivity? Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics Secrets of secretion revealed Effects of repeated botulinum toxin injections on orbicularis oculi muscle Intradetrusor injection of botulinum-A toxin in patients with idiopathic and neurogenic detrusor overactivity: urodynamic outcome and patient satisfaction
author name string	wds:Q83275316-9393BF4D-C80E-44FF-9B9D-2DABA7B19892 wds:Q83275316-CC32B659-0ED2-4CD6-9129-45B2CAB2F420 wds:Q83275316-F559C8F0-8C4A-46E4-B133-6A065E62CE9D
author name string	Mohammed A Al-Ghazo Ibrahim Fathi Ghalayini Ziad Ali Elnasser
rdfs:label	Is efficacy of repeated intradetrusor botulinum toxin type A (Dysport) injections dose dependent? Clinical and urodynamic results after four injections in patients with drug-resistant neurogenic detrusor overactivity (en) Is efficacy of repeated intradetrusor botulinum toxin type A (Dysport) injections dose dependent? Clinical and urodynamic results after four injections in patients with drug-resistant neurogenic detrusor overactivity (nl)
skos:prefLabel	Is efficacy of repeated intradetrusor botulinum toxin type A (Dysport) injections dose dependent? Clinical and urodynamic results after four injections in patients with drug-resistant neurogenic detrusor overactivity (en) Is efficacy of repeated intradetrusor botulinum toxin type A (Dysport) injections dose dependent? Clinical and urodynamic results after four injections in patients with drug-resistant neurogenic detrusor overactivity (nl)
name	Is efficacy of repeated intradetrusor botulinum toxin type A (Dysport) injections dose dependent? Clinical and urodynamic results after four injections in patients with drug-resistant neurogenic detrusor overactivity (en) Is efficacy of repeated intradetrusor botulinum toxin type A (Dysport) injections dose dependent? Clinical and urodynamic results after four injections in patients with drug-resistant neurogenic detrusor overactivity (nl)
title	wds:Q83275316-46CAB9F3-A262-471C-80F4-FFAE333B6673
title	Is efficacy of repeated intradetrusor botulinum toxin type A (Dysport) injections dose dependent? Clinical and urodynamic results after four injections in patients with drug-resistant neurogenic detrusor overactivity (en)
page(s)	wds:Q83275316-D051BBBD-D352-44B8-BE87-3F1CD266BE9F
page(s)	805-813
instance of	wds:Q83275316-DF423609-06DD-437E-BE59-780F7B59C2D5
instance of	scholarly article
main subject	wds:Q83275316-23EBE293-83FC-4153-924E-ABA59CA0F6A1
main subject	botulinum toxin type A
PubMed ID	wds:Q83275316-52B9B742-32B3-4A79-BDD1-9A3F8FAAEC4E
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19184509
PubMed ID	19184509
published in	wds:Q83275316-3C86BB91-D6A9-44D8-BBB9-CDF8671ECC21
published in	International Urology and Nephrology
issue	wds:Q83275316-8D3BE3AC-3F95-4D21-8F9C-DAA329CC94A7
volume	wds:Q83275316-70E0A4F2-2756-4728-AEEF-3ED4C80293C9
issue	4
volume	41
DOI	wds:Q83275316-24E21F0F-EB78-4710-B5D8-CEBC116EBE5C
DOI	http://dx.doi.org/10.1007/S11255-009-9528-Y
DOI	10.1007/S11255-009-9528-Y
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q83275316
is cites work of	Repeat botulinum toxin-A injections for treatment of adult detrusor overactivity Efficacy and safety of the first and repeated intradetrusor injections of abobotulinum toxin A 750 U for treating neurological detrusor overactivity. Intravesical instillation of botulinum toxin A: an in vivo murine study and pilot clinical trial. Treatment satisfaction and goal attainment with onabotulinumtoxinA in patients with incontinence due to idiopathic OAB. The use of botulinum toxin for the treatment of overactive bladder syndrome

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software